Clinical Trial Update: Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating anti-inflammatory lipid mediators for asthma. The study also includes obesity as a condition and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Obesity

Snippet

Sponsor: University of Colorado, Denver | Conditions: Asthma, Obesity | Phase 2 | Status: RECRUITING